ArticleBMC research notes2025
Predicting COVID-19 patient recovery or mortality using deep neural decision tree and forest.
Article in BMC research notes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Evidence-Guided Multimodal Risk Prediction Framework for Severe COVID-19 Outcomes Using EHR and CT Imaging for COVID-19 Clinical Decision Support.Bioengineering (Basel, Switzerland) · 2026Article
- Early prediction of severe Omicron pneumonia using a multimodal a.i. model integrating delta CT radiomics and laboratory indicators.Scientific reports · 2026Article
- Interpretable machine learning identifies immune-inflammatory and immunothrombotic biomarkers for myocardial injury and mortality risk stratification in severe pneumonia with diverse infectious etiologies.Frontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveIdentifying patients at high risk of mortality is crucial for emergency physicians to allocate hospital resources effectively, particularly in regions with limited medical services. This need becomes even more pressing during global health crises that lead to significant morbidity and mortality. This study aimed to evaluate the effectiveness of deep neural decision forests and deep neural decision trees in predicting mortality among COVID-19 patients. To achieve this, we utilized patient data encompassing COVID-19 diagnosis, demographics, health indicators, and occupational risk factors to analyze disease severity and outcomes. The dataset was partitioned using a stratified sampling method. Nine machine learning and deep learning methods were employed to build predictive models.
resultsAmong the models, the deep neural decision forest outperformed others. Results indicated that using only clinical data yielded an accuracy of 80.7%, recall of 80.7%, precision of 75.7%, and F1-score of 74.8% by deep neural decision forest, demonstrating it as a reliable predictor of patient mortality. The model differs from other machine learning approaches for COVID-19 mortality prediction by combining the representational power of deep neural networks with the structured decision-making of decision forests, enhancing interpretability and performance using only clinical data without reliance on imaging or laboratory tests.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.